Type A aortic dissection during pregnancy and postpartum: Experience in 60 patients over 25 years.
Jun-Ming Zhu, Su-Wei Chen, Wei-Guo Ma...
https://pubmed.ncbi.nlm.nih.gov/41520724/Actively Recruiting
Led by DeltaHealth Hospital · Shanghai · Updated on 2026-07-17
500
Participants Needed
4
Research Sites
23 weeks
Total Duration
Researchers are conducting a national multicenter observational study in China to understand pregnancy-related aortic dissection, a serious complication affecting mothers and newborns. This study tracks mothers and their babies to evaluate outcomes related to this condition, including associated syndromes such as Marfan, Loeys-Dietz, and vascular Ehlers-Danlos syndromes. The study aims to provide important information on maternal and neonatal health during and after pregnancy complicated by aortic dissection. Participants in this study will be observed based on their treatment strategies, which may include medication or surgery. The choice of intervention, such as delivery or surgical procedures, depends on the pregnancy stage, type of aortic dissection, and decisions made by the patient and her family. The study focuses on cases where aortic dissection occurs during pregnancy, labor, or up to 12 weeks postpartum. During the study, participants will be monitored for early-term mortality of mothers and newborns within 30 days after treatment, as well as long-term mortality up to about three years. Researchers will also track maternal adverse events and any developmental abnormalities in newborns over this period. The total participation duration spans from pregnancy through long-term follow-up, involving evaluations that include imaging confirmations and health assessments of both mother and child.
CONDITIONS
PregnAncy-Related Aortic DISsEction in China
S
Su-Wei Chen, MD, PhD
W
Wei-Guo Ma, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
DeltaHealth Hospital · Shanghai
Lead Sponsor
The Second Affiliated Hospital of Hainan Medical University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Jun-Ming Zhu, Su-Wei Chen, Wei-Guo Ma...
https://pubmed.ncbi.nlm.nih.gov/41520724/Jun-Ming Zhu, Wei-Guo Ma, Sven Peterss...
https://pubmed.ncbi.nlm.nih.gov/27825688/Wei-Guo Ma, Jun-Ming Zhu, Yu Chen...
https://pubmed.ncbi.nlm.nih.gov/32259204/DeltaHealth Hospital · Shanghai
Lead Sponsor
The Second Affiliated Hospital of Hainan Medical University
Collaborating Sponsor